Kingsway Education Group (KEG) Clinically Useful Papers (CUP) April 2022 Background: the importance of early recognition -
A patient with SBP is walking around with a belly full of pus (no bueno) SBP almost always occurs in patients with cirrhosis + ascites Renal failure develops in 30-40% of SBP patients and is a major cause of death = hepatorenal syndrome Like sepsis, SBP is a time-sensitive presentation needing prompt diagnosis and treatment Inpatient mortality ranges from 20-40%1,2 (about 2x mortality of an untreated STEMI) SBP with concomitant renal impairment: mortality up to 60%1 (about 3x mortality of an untreated STEMI) Delays in diagnosis and treatment are associated with an hourly increase in mortality!
Pathophysiology6 -
-
“spontaneous” descriptor was coined in 1964 as there was no obvious nidus for infection Cirrhosis → ascites → altered intestinal motility and increased permeability → bacterial translocation → rapid bacterial growth in ascites → peritonitis (SBP) SBP bacteria: E.coli > K. pneumoniae > Strep > other o So, ceftriaxone is a good choice empirically, but may not be the best option…
Clinical Presentation: SBP11 -
-
Key: up to 13% of SBP patients may have no clinical signs or symptoms at the time of diagnosis “SBP can be silent and if a patient is sick enough to come to hospital then a paracentesis to rule out SBP should always be done as SBP can be the precipitant to a bleed, encephalopathy, renal failure and all things liver-related”12 There are no clinical signs or symptoms with high sensitivity or specificity, however:11 o Fever: 69% o Abdominal pain: 59% o Altered Mental Status: 54% o Abdominal tenderness: 49% o Diarrhea: 32% o Paralytic ileus: 30% o Hypotension: 21% o Hypothermia: 17